US Stock MarketDetailed Quotes
ITRM Iterum Therapeutics
- 1.0800
- -0.0400-3.57%
Close Sep 6 16:00 ET
- 1.1200
- +0.0400+3.70%
Post 20:01 ET
24.52MMarket Cap-542P/E (TTM)
1.2200High1.0600Low869.18KVolume1.1400Open1.1200Pre Close985.01KTurnover3.96%Turnover RatioLossP/E (Static)22.71MShares2.500052wk High-2.25P/B23.72MFloat Cap0.622052wk Low--Dividend TTM21.96MShs Float195.0000Historical High--Div YieldTTM14.29%Amplitude0.6010Historical Low1.1330Avg Price1Lot Size
Iterum Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -73.81%11.72M | -64.85%18.21M | -60.64%23.93M | -60.64%23.93M | -44.23%35.89M | -35.09%44.73M | -31.15%51.82M | -25.28%60.8M | -25.28%60.8M | -26.87%64.36M |
| -Cash and cash equivalents | -63.77%4.98M | -56.10%7.39M | -71.22%6.07M | -71.22%6.07M | -76.49%4.82M | 49.14%13.73M | -46.33%16.83M | -23.15%21.09M | -23.15%21.09M | -43.06%20.49M |
| -Short-term investments | -78.25%6.74M | -69.06%10.83M | -55.03%17.86M | -55.03%17.86M | -29.16%31.08M | -48.08%31M | -20.31%34.99M | -26.37%39.71M | -26.37%39.71M | -15.68%43.87M |
| Receivables | 53.54%195K | -94.16%18K | -44.52%233K | -44.52%233K | -78.62%170K | -71.65%127K | -25.42%308K | -65.15%420K | -65.15%420K | -22.59%795K |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -40.44%81K |
| -Taxes receivable | 53.54%195K | -94.16%18K | -44.52%233K | -44.52%233K | -76.19%170K | -60.92%127K | -1.60%308K | -54.10%420K | -54.10%420K | -19.87%714K |
| Prepaid assets | -62.46%1.05M | -61.13%822K | 17.46%1.43M | 17.46%1.43M | 67.46%2.47M | 81.55%2.79M | 203.01%2.12M | 79.41%1.22M | 79.41%1.22M | 29.46%1.47M |
| Restricted cash | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30K |
| Current deferred assets | --734K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total current assets | -71.26%13.7M | -64.87%19.05M | -59.01%25.6M | -59.01%25.6M | -42.20%38.53M | -32.81%47.65M | -28.98%54.25M | -25.01%62.44M | -25.01%62.44M | -26.12%66.65M |
| Non current assets | ||||||||||
| Net PPE | -44.93%38K | -29.03%44K | -26.09%51K | -26.09%51K | 73.53%59K | 50.00%69K | 0.00%62K | -24.18%69K | -24.18%69K | -75.36%34K |
| -Gross PPE | -1.63%363K | 3.68%366K | 3.68%366K | 3.68%366K | 18.83%366K | 22.59%369K | -6.37%353K | -6.37%353K | -6.37%353K | -68.67%308K |
| -Accumulated depreciation | -8.33%-325K | -10.65%-322K | -10.92%-315K | -10.92%-315K | -12.04%-307K | -17.65%-300K | 7.62%-291K | 0.70%-284K | 0.70%-284K | 67.57%-274K |
| Goodwill and other intangible assets | ---- | ---- | --0 | --0 | -79.89%432K | -66.59%861K | -57.09%1.29M | -49.96%1.72M | -49.96%1.72M | --2.15M |
| Other non current assets | -81.91%441K | -79.10%527K | -76.47%612K | -76.47%612K | -73.91%710K | -22.31%2.44M | -45.34%2.52M | -44.86%2.6M | -44.86%2.6M | -66.29%2.72M |
| Total non current assets | -85.78%479K | -85.26%571K | -84.89%663K | -84.89%663K | -75.50%1.2M | -41.54%3.37M | -49.57%3.87M | -46.75%4.39M | -46.75%4.39M | -40.27%4.9M |
| Total assets | -72.22%14.17M | -66.23%19.63M | -60.71%26.26M | -60.71%26.26M | -44.48%39.73M | -33.47%51.02M | -30.86%58.12M | -26.97%66.83M | -26.97%66.83M | -27.30%71.56M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -77.87%822K | 33.20%2.98M | 80.10%5M | 80.10%5M | 352.40%5.56M | 322.64%3.72M | 67.79%2.24M | 152.41%2.77M | 152.41%2.77M | 194.72%1.23M |
| -accounts payable | -77.87%822K | 32.71%2.97M | 80.10%5M | 80.10%5M | 348.66%5.51M | 372.05%3.72M | 226.75%2.24M | 215.95%2.77M | 215.95%2.77M | 345.29%1.23M |
| -Total tax payable | ---- | --11K | ---- | ---- | --46K | ---- | ---- | ---- | ---- | --0 |
| Current accrued expenses | -56.29%2.26M | -48.35%1.86M | 78.58%7.76M | 78.58%7.76M | 142.47%9.05M | 75.05%5.17M | 82.51%3.6M | 273.05%4.35M | 273.05%4.35M | 120.83%3.73M |
| Current debt and capital lease obligation | --12.95M | --12.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Current debt | --12.95M | --12.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current liabilities | -61.86%741K | -61.54%755K | -60.85%761K | -60.85%761K | -29.87%1.79M | -46.91%1.94M | -71.03%1.96M | -78.52%1.94M | -78.52%1.94M | -79.58%2.55M |
| Current liabilities | 54.91%16.78M | 128.22%17.79M | 49.14%13.52M | 49.14%13.52M | 118.35%16.4M | 44.52%10.83M | -22.66%7.8M | -29.96%9.06M | -29.96%9.06M | -57.88%7.51M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -74.01%8.3M | -73.52%7.98M | -33.41%18.96M | -33.41%18.96M | -35.15%19.59M | 35.40%31.92M | 36.30%30.14M | 14.33%28.47M | 14.33%28.47M | 23.14%30.22M |
| -Long term debt | -74.01%8.3M | -73.82%7.89M | -33.41%18.96M | -33.41%18.96M | -35.15%19.59M | 35.40%31.92M | 36.30%30.14M | 14.33%28.47M | 14.33%28.47M | 23.14%30.22M |
| -Long term capital lease obligation | ---- | --92K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non current liabilities | -98.60%16K | ---- | -85.58%188K | -85.58%188K | -76.05%307K | -33.95%1.15M | -61.97%1.23M | -62.05%1.3M | -62.05%1.3M | -64.47%1.28M |
| Total non current liabilities | -74.86%8.31M | -74.56%7.98M | -35.69%19.14M | -35.69%19.14M | -36.82%19.9M | 30.64%33.06M | 23.75%31.37M | 5.07%29.77M | 5.07%29.77M | 11.91%31.5M |
| Total liabilities | -42.84%25.09M | -34.19%25.78M | -15.89%32.66M | -15.89%32.66M | -6.95%36.3M | 33.81%43.89M | 10.54%39.16M | -5.91%38.83M | -5.91%38.83M | -15.16%39.01M |
| Shareholders'equity | ||||||||||
| Share capital | 27.69%166K | 28.91%165K | 7.14%135K | 7.14%135K | 6.56%130K | -92.92%130K | -93.02%128K | 3.28%126K | 3.28%126K | -93.32%122K |
| -common stock | 27.69%166K | 28.91%165K | 7.14%135K | 7.14%135K | 6.56%130K | -92.92%130K | -93.02%128K | 3.28%126K | 3.28%126K | -93.32%122K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -6.37%-473.4M | -8.22%-468.4M | -9.07%-461.3M | -9.07%-461.3M | -7.44%-448.94M | -14.49%-445.06M | -13.30%-432.82M | -11.74%-422.93M | -11.74%-422.93M | -11.63%-417.84M |
| Paid-in capital | 2.26%462.32M | 2.28%462.08M | 0.80%454.76M | 0.80%454.76M | 0.44%452.24M | 4.95%452.08M | 5.36%451.78M | 5.26%451.15M | 5.26%451.15M | 5.96%450.26M |
| Gains losses not affecting retained earnings | 96.15%-1K | --0 | 100.29%1K | 100.29%1K | --3K | ---26K | ---131K | ---350K | ---350K | ---- |
| Total stockholders'equity | -253.08%-10.91M | -132.44%-6.15M | -122.87%-6.4M | -122.87%-6.4M | -89.46%3.43M | -83.76%7.13M | -61.02%18.96M | -44.26%28M | -44.26%28M | -37.94%32.55M |
| Total equity | -253.08%-10.91M | -132.44%-6.15M | -122.87%-6.4M | -122.87%-6.4M | -89.46%3.43M | -83.76%7.13M | -61.02%18.96M | -44.26%28M | -44.26%28M | -37.94%32.55M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg